Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

The Council of Europe's Committee of Experts on Blood Transfusion and Immunohaematology, which included Dr Gunson, published a report addressing surrogate screening for NANBH.

  • Read more about The Council of Europe's Committee of Experts on Blood Transfusion and Immunohaematology, which included Dr Gunson, published a report addressing surrogate screening for NANBH.

A letter published in the The Lance by Dr Contreras and colleagues at the North London Blood Transfusion Centre commented that if "the true incidence of post-transfusion NANB hepatitis and its serious clinical sequelae are at a much lower level than reported from the USA, then screening of donations to reduce the incidence of NANB hepatitis may not be cost effective in the UK".

  • Read more about A letter published in the The Lance by Dr Contreras and colleagues at the North London Blood Transfusion Centre commented that if "the true incidence of post-transfusion NANB hepatitis and its serious clinical sequelae are at a much lower level than reported from the USA, then screening of donations to reduce the incidence of NANB hepatitis may not be cost effective in the UK".

Dr Gunson completed a funding application for a multi-centre study into surrogate testing and ALT.

  • Read more about Dr Gunson completed a funding application for a multi-centre study into surrogate testing and ALT.

Dr Scott in an internal minute written to Dr McIntyre believed "we should prevent the BTS from doing a full scale introduction" of surrogate testing.

  • Read more about Dr Scott in an internal minute written to Dr McIntyre believed "we should prevent the BTS from doing a full scale introduction" of surrogate testing.

In oral evidence given to the Inquiry, Dr Morris McClelland explained that he could not recall whether the SNBTS guidelines regarding surrogate testing were adhered to and he followed "National decision making" in reference to surrogate testing in Northern Ireland.

  • Read more about In oral evidence given to the Inquiry, Dr Morris McClelland explained that he could not recall whether the SNBTS guidelines regarding surrogate testing were adhered to and he followed "National decision making" in reference to surrogate testing in Northern Ireland.


De Kernoff and Dr Colvin stated in a paper for the Haemophilia Working Party that the acute NANBH, appeared generally mild, though might sometimes be fatal, but the chronic NANBH seemed "very possible that there may be serious long-term sequelae"

  • Read more about De Kernoff and Dr Colvin stated in a paper for the Haemophilia Working Party that the acute NANBH, appeared generally mild, though might sometimes be fatal, but the chronic NANBH seemed "very possible that there may be serious long-term sequelae"

Professor Cash wrote to Dr Gunson, suggesting he should not take the content of the minutes in relation to surrogate testing "too seriously at this stage" as "the results of the UK study are unlikely to have a material affect [sic] on future operational practice."

  • Read more about Professor Cash wrote to Dr Gunson, suggesting he should not take the content of the minutes in relation to surrogate testing "too seriously at this stage" as "the results of the UK study are unlikely to have a material affect [sic] on future operational practice."

Dr Gunson wrote that it was incorrect that "no Scottish Centre was now being asked to participate" in the multi-centre study and that he was "dismayed" to read SNBT would be applying for funding for surrogate testing from 1 April 1988, as he had understood that "Scotland would not take unilateral action" in introducing surrogate testing without consultation with regional transfusion directors in England and Wales

  • Read more about Dr Gunson wrote that it was incorrect that "no Scottish Centre was now being asked to participate" in the multi-centre study and that he was "dismayed" to read SNBT would be applying for funding for surrogate testing from 1 April 1988, as he had understood that "Scotland would not take unilateral action" in introducing surrogate testing without consultation with regional transfusion directors in England and Wales

Dr Moir wrote to Dr Forrester expressing reservations against providing funding for a research project involving one Scottish Transfusion Centre

  • Read more about Dr Moir wrote to Dr Forrester expressing reservations against providing funding for a research project involving one Scottish Transfusion Centre

Dr Forrester wrote to Dr Moir seeking agreement in principle of CSO that funding for the scottish component of a research project can be sought

  • Read more about Dr Forrester wrote to Dr Moir seeking agreement in principle of CSO that funding for the scottish component of a research project can be sought

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 693
  • Page 694
  • Page 695
  • Page 696
  • Current page 697
  • Page 698
  • Page 699
  • Page 700
  • Page 701
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.